New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - conjugated estrogens 1.25mg;   - tablet - 1.25 mg - active: conjugated estrogens 1.25mg   excipient: calcium sulfate carnauba wax glyceryl mono-oleate ink lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose quinoline yellow shellac stearic acid sucrose sunset yellow fcf titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - conjugated estrogens 0.625 mg/g - vaginal cream - 0.62 mg/g - active: conjugated estrogens 0.625 mg/g excipient: benzyl alcohol cetyl alcohol cetyl esters wax glycerol liquid paraffin methyl stearate propylene glycol monostearate purified water self-emulsifying glyceryl monostearate sodium laurilsulfate white beeswax

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - conjugated estrogens 0.625mg (15mg dessication with lactose,includes 3% overage);  ; medroxyprogesterone acetate 5mg (5.2mg includes 4% overage);  ; conjugated estrogens 0.625mg - tablet - active: conjugated estrogens 0.625mg (15mg dessication with lactose,includes 3% overage)   medroxyprogesterone acetate 5mg (5.2mg includes 4% overage)   excipient: calcium sulfate carnauba wax glyceryl mono-oleate indigo carmine lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose   opacode black s-8-27741 povidone shellac stearic acid sucrose     titanium dioxide   active: conjugated estrogens 0.625mg excipient: calcium sulfate carnauba wax glyceryl mono-oleate ink lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose shellac stearic acid sucrose titanium dioxide urethane dimethacrylate luting resin

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - conjugated estrogens 0.625mg;  ; norgestrel 0.15mg - tablet - 0.62 mg - active: conjugated estrogens 0.625mg   excipient: calcium sulfate carnauba wax glyceryl mono-oleate lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opaglos clear 98z19173 shellac stearic acid sucrose titanium dioxide urethane dimethacrylate luting resin active: norgestrel 0.15mg excipient: calcium carbonate carnauba wax iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide white beeswax

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - conjugated estrogens 1.25mg;  ; norgestrel 0.15mg - tablet - 1.25 mg - active: conjugated estrogens 1.25mg   excipient: calcium sulfate carnauba wax glyceryl mono-oleate ink lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose quinoline yellow shellac stearic acid sucrose sunset yellow fcf titanium dioxide active: norgestrel 0.15mg excipient: calcium carbonate carnauba wax iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide white beeswax

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - guanabenz acetate - tablet - 4mg, 8mg, 16mg - active: guanabenz acetate

United States - English - NLM (National Library of Medicine)

wyeth biopharma division of wyeth pharmaceuticals llc - coagulation factor ix recombinant human (unii: 382l14738l) (coagulation factor ix recombinant human - unii:382l14738l) - coagulation factor ix recombinant human 1000 [iu] in 5 ml - benefix® , coagulation factor ix (recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia b (congenital factor ix deficiency or christmas disease) for: limitation of use benefix is not indicated for induction of immune tolerance in patients with hemophilia b [see warnings and precautions (5.3)] . benefix is contraindicated in patients who have manifested life-threatening, immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster protein. risk summary there are no data with benefix use in pregnant women to inform a drug-associated risk. animal reproduction studies have not been conducted with benefix. it is not known whether benefix can affect reproductive capacity or cause fetal harm when given to pregnant women. in the u.s. general population, the estimated background risk of major birth defect and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively. risk summary there is no informa

United States - English - NLM (National Library of Medicine)

wyeth biopharma division of wyeth pharmaceuticals llc - moroctocog alfa (unii: 113e3z3cjj) (moroctocog alfa - unii:113e3z3cjj) - antihemophilic factor, human recombinant residues 743-1636 deleted 1000 [iu] in 4 ml - xyntha, antihemophilic factor (recombinant), is indicated for use in adults and children with hemophilia a (congenital factor viii deficiency) for: xyntha does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand's disease. xyntha is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster proteins. risk summary it is not known whether xyntha can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. animal reproduction studies have not been conducted with xyntha. there is no information available on the effect of factor viii replacement therapy on labor and delivery. xyntha should be used only if clinically indicated. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively. risk summary there is

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oestradiol -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oestradiol; oestradiol hemihydrate -